About AMSilk
AMSilk is a company based in Neuried (Germany) founded in 2008 by Thomas Scheibel. AMSilk has raised $130.38 million across 6 funding rounds from investors including Cargill, RollKall and Novo Holdings. The company has 61 employees. AMSilk offers products and services including Silk Protein Materials, Fiber Products, and MedTech Materials. AMSilk operates in a competitive market with competitors including Cocoon Biotech and Spintex, among others.
- Headquarter Neuried, Germany
- Employees 61
- Founders Thomas Scheibel
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website amsilk.com
- Social LinkedIn X Instagram
- Legal Name Amsilk Gmbh
- Annual Revenue$33.51 K (USD)-7as on Dec 31, 2016
- Net Profit-$4.14 M (USD)3as on Dec 31, 2016
- EBITDA-$4.13 M (USD)3as on Dec 31, 2016
- Total Equity Funding$130.38M (USD)
in 6 rounds
- Latest Funding Round$61.02M (USD), Series D
Sep 2025
- InvestorsCargill
& 6 more
- Employee Count61
Products & Services of AMSilk
AMSilk offers a comprehensive portfolio of products and services, including Silk Protein Materials, Fiber Products, and MedTech Materials.
Sustainable proteins for innovative fiber and MedTech applications
Recyclable fibers from silk proteins for performance-driven uses
Biocompatible silk-based products for biomedical advancements
Funding Insights of AMSilk
AMSilk has successfully raised a total of $130.38M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $61.02 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $130.38M
- Total Rounds 6
- Last Round Series D — $61.02M
- Investors Count 7
All 6 funding rounds of AMSilk with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $61.02M | Series D | – | AT Newtec | |
| Apr 2023 | $27.14M | Series C | – | Athos Group | |
| May 2021 | $35.25M | Series C | – | Novo Holdings, Cargill | |
| Jul 2016 | – | Series C | – | – | – |
| Mar 2011 | $6.98M | Series B | – | – | |
| Jun 2008 | – | Series A | – | – | – |
7 investors in total: 7 institutional.
Investors in AMSilk
AMSilk has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Cargill, RollKall and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | – | novoholdings.dk | Hellerup, Denmark | |
VC Firm funding companies in Europe | – | mig.ag | Munich, Germany | |
Venture capital investments in technology companies are managed by MIG Fonds. | – | mig-fonds.de | Germany | |
RollKall is recognized as a leading technology platform for off-duty law enforcement management. | 2006 | athosgroup.com | Irving, United States | |
Food, ingredients, agricultural solutions, and industrial products are provided globally. | 1865 | cargill.com | Minneapolis, United States | |
Manages diversified investment portfolios across various asset classes. | 2008 | er-capital.com | Hamburg, Germany | |
- | – | atnewtec.tcc.mode | - |
Investor details for AMSilk
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AMSilk
3 people are tracked at AMSilk (3 in leadership); the tracked headcount is 61.
| Name | Role | Group |
|---|---|---|
Thomas Scheibel | Co-Founder | Leadership |
Ralph Fraundorfer | CFO | Leadership |
Ulrich Scherbel | CEO | Leadership |
Complete people profiles for AMSilk
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AMSilk
3 dated milestones of AMSilk across 17 years, from founding to its latest funding, stage changes and deals.
- Founded AMSilk is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $61.0M.
Competitors of AMSilk
AMSilk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cocoon Biotech and Spintex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cocoonbiotech.com | 2013 | Boston, United States | $2.88M | 3 | Provider of a biocompatible silk protein for the treatment of osteoarthritis and other degenerative joint disorders | |
| spintex.co.uk | 2018 | Oxford, United Kingdom | $463,853 | 2 | Developer of sustainable textiles using silk materials |
Detailed competitors of AMSilk
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AMSilk
The website of AMSilk (amsilk.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 99.4% vs previous month
Websites whose visitors overlap most with AMSilk. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
performanceff.com | performanceff.com | 100% | – | – | – |
poolecompany.com | poolecompany.com | 99% | – | #13,551,385 | – |
| fi-tech.com | 98% | – | #3,706,921 | View details | |
creafibres.fr | creafibres.fr | 98% | – | – | – |
cranenonwovens.com | cranenonwovens.com | 98% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 35 similar websites and full traffic analytics for AMSilk
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 35 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Amsilk
Complete news archive for AMSilk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AMSilk
10 companies that operate in the same segment as AMSilk (Battery & Advanced Material Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
AI and app-based smart windows are provided for buildings. | 2007 | Milpitas, California, United States | USD 3.71 B | – | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Mycelium-based leather alternative fabrics are manufactured and provided. | 2009 | Emeryville, California, United States | USD 219.4 M | USD 1.37 M | 22 | |
Bio-based materials from mycelium are manufactured as sustainable leather alternatives. | 2013 | Emeryville, California, United States | USD 225.3 M | – | – | |
Manufacturer of carbon fiber composites for multiple industrial applications | 2018 | Berkeley, California, United States | USD 233.13 M | – | – | |
Developr of bio-based products and natural compounds for biotechnological solutions | 1993 | Zwingenberg, Hesse, Germany | USD 5.38 M | – | – | |
Sustainable biodegradable materials are developed using mycelium technology. | 2007 | Albany, United States | USD 183.93 M | – | 106 | |
Technology is developed to convert carbon dioxide into raw materials. | 2011 | Macclesfield, Cheshire, United Kingdom | USD 43.19 M | – | – | |
Meta-optic materials are manufactured for applications in sensing and electronics. | 2016 | Weston, Florida, United States | USD 47.4 M | – | 26 | |
Biodegradable packaging materials are manufactured from crop stubble waste. | 2020 | Delhi, Delhi, India | USD 3.45 M | USD 45.41 K | 55 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMSilk
AMSilk was founded in 2008.
AMSilk is headquartered in Neuried, Germany. It is registered at Neuried, Bavaria, Germany.
Ulrich Scherbel is the current CEO of AMSilk.
AMSilk is a funded company, having raised a total of $130.38M across 6 funding rounds to date.
AMSilk has 61 employees.
Annual revenue of AMSilk is $33.51K as on Dec 31, 2016.
Founded in 2008 and based in Neuried, Germany, operations are centered on the biotechnology sector. Biogenic materials derived from silk proteins are produced through DNA editing and protein engineering. These are processed into fibers, yarns, sprayable formulations, hydrogels, and powders. Applications are found in textiles, medical devices, and consumer goods, with emphasis placed on biobased options that reduce environmental impact relative to traditional materials.
AMSilk's top competitors include Cocoon Biotech and Spintex.
AMSilk offers Silk Protein Materials, Fiber Products, and MedTech Materials.
AMSilk has 7 investors. Key investors include Cargill, RollKall, Novo Holdings, MIG Capital, and E R CAPITAL HOLDING.
AMSilk operates through Amsilk Gmbh.